NOVT

Novanta Inc.

Price

$150.46

return (12m)

43.94%

p/e

99.90

p/bv

3.82

DIVIDEND YIELD

0.00%

NOVT price

Novanta

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NOVT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.98%

3 months

-9.20%

1 year

43.94%

2 years

-12.44%

5 years

-1.70%

10 years

760.76%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NOVT

Valuation

P/E

99.90

Sector 1.27

Industry 8.57

P/BV

3.82

Sector 1.88

Industry 3.63

P/Revenue (PSR)

5.99

Sector 1.56

Industry 3.09

EV/EBITDA

124.75

Sector -46.85

Industry -17.98

EV/EBIT

184.55

Sector -51.35

Industry -94.21

P/EBITDA

33.99

Sector -31.66

Industry 7.07

P/EBIT

51.45

Sector -43.19

Industry -32.11

P/Total Assets

2.88

Sector 0.87

Industry 1.32

P/Net Current Assets

10.28

Sector -26.04

Industry -3.44

P/Working Capital

7.03

Sector -4.00

Industry 7.65

EPS

1.51

Sector -0.70

Industry -0.23

BVPS

39.42

Sector 4.48

Industry 8.61

Efficiency

Gross Margin

44.54%

Sector 49.44%

Industry 55.16%

EBITDA Margin

17.01%

Sector -282.02%

Industry -13.47%

EBIT Margin

11.50%

Sector -164.03%

Industry -25.89%

Operating Margin

8.96%

Sector -19.60%

Industry -5.67%

Net Profit Margins

6.00%

Sector -23.82%

Industry -7.67%

Asset Turnover

0.12

Sector 0.13

Industry 0.13

Profitability

ROE

3.82%

Sector -23.80%

Industry -24.00%

ROA

2.89%

Sector -24.22%

Industry -5.96%

ROIC

7.43%

Sector -587.47%

Industry -21.90%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

4.57

Sector 1.90

Industry 2.56

Net Debt / EBITDA

-11.73

Sector -23.34

Industry 9.41

Net Debt / EBIT

-17.36

Sector -11.26

Industry -2.82

Net Debt / Equity

-0.33

Sector -0.63

Industry -0.19

Gross Debt / Equity

0.12

Sector -0.73

Industry 0.42

Equity/Assets

0.76

Sector 0.46

Industry 0.50

Liabilities/Assets

0.24

Sector 0.50

Industry 0.53

Growth

5Y Revenue CAGR

7.82%

Sector -

Industry -

5Y Earnings CAGR

4.18%

Sector -

Industry -

Fundamentals NOVT

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Novanta ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$150.46

Fair Value

$36.60

Upside

-75.68%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NOVT Novanta Inc.	$150.46	49.24%	0.00%	99.90	3.82	3.82%	6.00%
ABT Abbott Laboratories	$96.56	-25.26%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$86.94	-4.56%	3.30%	21.10	2.17	10.29%	13.93%
BSX Boston Scientific Corp.	$42.80	-55.35%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$77.58	-32.47%	0.00%	17.68	5.18	29.28%	22.69%
RMD ResMed Inc.	$220.18	-17.85%	1.12%	20.92	4.84	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$520.16	-16.12%	0.00%	36.04	25.47	70.67%	25.03%
COHR Coherent Inc.	$336.58	193.57%	0.00%	81.57	5.84	7.16%	11.31%
SYK Stryker Corp.	$275.16	-23.42%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$23.86	-10.29%	4.25%	17.60	1.72	9.80%	6.30%
INMD InMode Ltd.	$14.05	-8.08%	0.00%	10.69	1.32	12.32%	20.69%
BDX Becton Dickinson and Company	$176.01	-5.53%	2.39%	51.40	1.98	3.85%	6.29%
DXCM DexCom Inc.	$85.41	29.25%	0.00%	32.65	12.45	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.35	11.85%	0.00%	48.96	4.59	9.37%	15.43%
ALGN Align Technology Inc.	$145.01	13.72%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$26.32	-25.97%	2.96%	19.66	4.27	21.74%	9.20%
IRMD iRadimed Corporation	$85.25	22.44%	1.49%	47.27	10.71	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$87.75	-10.09%	1.10%	20.85	1.33	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NOVT - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Novanta

Novanta Inc.

Average Investor10 user rating

4.0 (1 people)

United States

56 years

Founded: 1970

1999

Time since IPO - 27 years

1.269

Employees

Novanta Inc. (United States) is listed on the Nasdaq and has a market capitalization of $6.17 billion, with shareholders equity totaling $1.62 billion.

The company employs approximately 1.269 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Novanta Inc. reported $1.03 billion in revenue, generating net income of $61.76 million.

Key financial metrics include a P/E ratio of 99.90, a price-to-book (P/B) ratio of 3.82, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NOVT.

Market cap

$6.17 billion

Net worth

$1.62 billion

$1,616,458,000.00

Assets

$2.14 billion

$2,139,565,000.00

Total Shares Outstanding

41.01 million

41,009,000

Average Daily Trading Volume

$385.45 Thousand

$385,453.24

Sector

Health

Industry

Medical Supplies and Equipment

NOVT

NOVT revenue and profits

Financial Results NOVT

DRAG THE FRAME TO SEE MORE DATA

NOVT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.67 15,38% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$267.68 --11,99% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$62.50 61,49% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$383.17 37,00% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.70 --18,93% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$255.81 38,68% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,139.27 36,51% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$428.58 0,25% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45